StockTipsArenaBeta

BUY Poly Medicure Limited — Deven Mehata, IDBI Capital Markets and Securities

BUYPoly Medicure Limited

byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1–3 months)1 Jul 2026via NDTV Profit (Live)

Entry₹1,687.4Stated
Target₹1,845
Total upside +9.34% (call closed)
Stop loss₹1,615-4.29% risk
Exit₹1,6158 Jul 2026, 12:00 am
Stop-loss hit-4.29%
Follow Deven Mehata for new callsGet alertsWatch POLYMED for new buy/sell callsGet alertsSee 89 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Sept, 11:57 pm IST
0 supporting1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Poly Medicure received an order from the Office of Divisional Commissioner, Delhi, imposing a stamp duty of Rs. 1 crore and penalty of Rs. 1.5 crore. The company disputes the order and is pursuing leg

BSE · Company Update·16 Jun · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.